A randomized trial of bupropion and/or nicotine gum as maintenance treatment for preventing smoking relapse
Abstract
Aim To investigate the efficacy of maintenance treatment with bupropion and/or nicotine gum for reducing smoking relapse.Design, setting and participants A 48‐week study was conducted at a university‐based smoking cessation clinic between February 2001 and October 2005. A total of 588 smokers received bupropion and nicotine patch in 8 weeks of open‐label treatment (OLT); 289 abstainers during the last 4 weeks of OLT were randomized in double‐blind placebo‐controlled fashion to one of four arms for 16 weeks of maintenance treatment (MT) followed by 24 weeks of non‐treatment follow‐up (NTFU).Intervention Bupropion (300 mg/day) and 2 mg nicotine gum, used alone or combined, and comparable placebo pill and placebo gum. Behavioral counseling at all visits.Outcome Time to relapse (TTR) from randomization. Relapse is defined as the first 7 consecutive days of smoking. Abstinence verified by carbon monoxide ≤ 8 parts per million.Findings TTR was longer with extended active treatments compared to placebo (median days to relapse: bupropion + placebo = 136, nicotine + placebo = 98, bupropion + nicotine = 90, double placebo = 71). Hazard ratios (HR) for relapse were statistically significant for bupropion + placebo versus double placebo during MT (HR = 0.59, 95% CI = 0.37–0.92) and to the end of NTFU (HR = 0.66, 95% CI = 0.42–0.96). However, bupropion's advantage dissipated upon stopping the drug. Gum use was low, preventing a valid assessment; but analysis restricted to gum users suggested a weak effect of extended nicotine gum.Conclusion Maintenance treatment with bupropion exerted a modest benefit for preventing smoking relapse; the optimum duration of bupropion treatment was unclear. Further research is needed to ascertain the merits of extended use of nicotine gum, other nicotine replacement agents and other treatments known to aid smokers for preventing relapse once abstinence is achieved.Keywords
This publication has 27 references indexed in Scilit:
- Errors in interpreting abstinence curves in studies of smoking cessationNicotine & Tobacco Research, 2006
- 3,5-Bicyclic aryl piperidines: A novel class of α4β2 neuronal nicotinic receptor partial agonists for smoking cessationBioorganic & Medicinal Chemistry Letters, 2005
- Relapse prevention interventions for smoking cessation2005
- Extended Nortriptyline and Psychological Treatment for Cigarette SmokingAmerican Journal of Psychiatry, 2004
- Stress and Relapse to Drug Seeking: Studies in Laboratory Animals Shed Light on Mechanisms and Sources of Long‐Term VulnerabilityThe American Journal on Addictions, 2003
- Naltrexone Effects on Short-Term and Long-Term Smoking CessationJournal of Addictive Diseases, 1999
- Higher dosage nicotine patches increase one‐year smoking cessation rates: results from the European CEASE trialEuropean Respiratory Journal, 1999
- The Fagerström Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance QuestionnaireBritish Journal of Addiction, 1991
- Debunking myths about self-quitting: Evidence from 10 prospective studies of persons who attempt to quit smoking by themselves.American Psychologist, 1989
- Task Force 1: Classification and assessment of smoking behavior.Health Psychology, 1986